Double-blind randomized phase II trial of carboplatin and pemetrexed with or without OGX-427 in patients with previously untreated stage IV non-squamous non-small-cell lung cancer (NSCLC): The Spruce Clinical Trial.
David R. Spigel
No relevant relationships to disclose
Howard A. Burris
No relevant relationships to disclose
F Anthony Greco
No relevant relationships to disclose
John D. Hainsworth
No relevant relationships to disclose